Cargando…
Correction: Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
Autores principales: | Nayak, Seema, Bhatt, M. L. B., Goel, Madhu Mati, Gupta, Seema, Mahdi, Abbas Ali, Mishra, Anupam, Mehrotra, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085057/ https://www.ncbi.nlm.nih.gov/pubmed/30092098 http://dx.doi.org/10.1371/journal.pone.0202432 |
Ejemplares similares
-
Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy
por: Nayak, Seema, et al.
Publicado: (2018) -
Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma
por: Nayak, Seema, et al.
Publicado: (2015) -
Phosphatase and Tensin Homolog Immunohistochemical Expression and Promoter Methylation Status in Endometrioid Endometrial Carcinoma and Its Precursor Lesions
por: Yadav, Sunita, et al.
Publicado: (2022) -
Increased Expression of Oct4, Nanog and CD24 Predicts Poor Response to Chemo-Radiotherapy and Unfavourable Prognosis in Locally Advanced Oral Squamous Cell Carcinoma
por: Mishra, Sridhar, et al.
Publicado: (2020) -
Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC)
por: Shojaeian, Sorour, et al.
Publicado: (2021)